Skip to main content
Clinical Trials/NCT03423420
NCT03423420CompletedNot Applicable

High Central Venous Pressure After Cardiac Surgery is Associated With Increased Morbidity and Mortality

Charite University, Berlin, Germany1 site in 1 country5,945 target enrollmentStarted: January 1, 2006Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
5,945
Locations
1
Primary Endpoint
mortality

Study Overview

Brief Summary

Recent studies indicated the central venous pressure (CVP) as a prognostic marker. Therefore, we retrospectively analyzed the CVP on admission to the intensive care unit (ICU) in cardiac surgery patients regarding its prognostic value for morbidity and mortality.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • In-patients of the Charité Universitätsmedizin Berlin
  • at least 18 years old
  • female or male sex
  • cardiosurgical intervention (OPS 5.35 and 5.36) between 01/06 and 12/
  • post-operative monitoring of anesthesiological intensive care unit

Exclusion Criteria

  • previous cardiosurgical interventions during the same hospital stay.
  • incomplete documentation

Outcomes

Primary Outcomes

mortality

Time Frame: an average of 30 days

In-Hospital mortality

Secondary Outcomes

  • mortality rate-1(90 days)
  • mortality rate-5(5 years)
  • mortality rate-2(180 days)
  • Central venous pressure(intensive care unit stay, an average of 5 days)
  • ICU stay(an average of 5 days)
  • Renal insufficiency - 3(intensive care unit stay, an average of 5 days)
  • Stroke(hospital length of stay, an average of 13 days)
  • Hospital stay(an average of 13 days)
  • ICU readmission(an average of 30 days)
  • Renal insufficiency - 1(intensive care unit stay, an average of 5 days)
  • Renal insufficiency - 2(intensive care unit stay, an average of 5 days)
  • mortality rate-4(1 year)
  • mortality rate-3(3 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Felix Balzer

Prof. Dr. med. Dr. rer. nat., MSc

Charite University, Berlin, Germany

Study Sites (1)

Loading locations...

Similar Trials

Pontos-Central Venous Pressure and Cardiac... | Clinical Trial